Castle Biosciences is a molecular diagnostics company offering proprietary gene expression profile (GEP) and spatialomics tests to aid clinicians in diagnosing and treating dermatologic cancers, Barrett's esophagus, atopic dermatitis, and uveal melanoma. Its portfolio includes DecisionDx-Melanoma, DecisionDx-SCC, TissueCypher, MyPath Melanoma, DecisionDx-UM, and AdvanceAD-Tx. The company uses multi-analyte assays with algorithmic analysis to generate clinically actionable, personalized patient information, supported by approximately 158 peer-reviewed publications.
Q2 FY2026 — expected 2026-08-04
| Type | Subject | Detail | Quarter |
|---|---|---|---|
| topic_mention | CSTL | discussed Supply Chain | |
| topic_mention | CSTL | discussed Regulation | |
| topic_mention | CSTL | discussed Automotive |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001628280-26-012272 | EDGAR | 96K words |
| 2025-02-27 | 2024-12-31 | 0001447362-25-000031 | EDGAR | 95K words |
| 2024-02-28 | 2023-12-31 | 0001447362-24-000017 | EDGAR | 90K words |
| 2023-02-28 | 2022-12-31 | 0001447362-23-000038 | EDGAR | 104K words |
| 2022-02-28 | 2021-12-31 | 0001447362-22-000045 | EDGAR | 96K words |
| 2021-03-11 | 2020-12-31 | 0001447362-21-000047 | EDGAR | — |
| 2020-03-10 | 2019-12-31 | 0001447362-20-000029 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-07-30 | 2026-06-30 | 0001628280-26-051052 | EDGAR | 29K words |
| 2025-11-03 | 2025-09-30 | 0001628280-25-048254 | EDGAR | 33K words |
| 2025-08-04 | 2025-06-30 | 0001447362-25-000097 | EDGAR | 32K words |
| 2025-05-05 | 2025-03-31 | 0001447362-25-000069 | EDGAR | 28K words |
| 2024-11-04 | 2024-09-30 | 0001447362-24-000169 | EDGAR | 31K words |
| 2024-08-05 | 2024-06-30 | 0001447362-24-000122 | EDGAR | 29K words |
| 2024-05-02 | 2024-03-31 | 0001447362-24-000060 | EDGAR | 24K words |
| 2023-11-02 | 2023-09-30 | 0001447362-23-000147 | EDGAR | 36K words |
| 2023-08-02 | 2023-06-30 | 0001447362-23-000128 | EDGAR | 34K words |
| 2023-05-03 | 2023-03-31 | 0001447362-23-000067 | EDGAR | 62K words |
| 2022-11-02 | 2022-09-30 | 0001447362-22-000172 | EDGAR | 67K words |
| 2022-08-08 | 2022-06-30 | 0001447362-22-000137 | EDGAR | 65K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-30 | 0001628280-26-051045 | EDGAR | 6K words |
| 2026-02-26 | 0001628280-26-012263 | EDGAR | 7K words |
| 2026-01-13 | 0001628280-26-001909 | EDGAR | 1K words |
| 2025-11-03 | 0001628280-25-048248 | EDGAR | 7K words |
| 2025-08-08 | 0001447362-25-000099 | EDGAR | 17K words |
| 2025-08-04 | 0001447362-25-000096 | EDGAR | 7K words |
| 2025-05-23 | 0001447362-25-000085 | EDGAR | 1K words |
| 2025-05-05 | 0001447362-25-000068 | EDGAR | 6K words |
| 2025-02-27 | 0001447362-25-000030 | EDGAR | 6K words |
| 2025-01-13 | 0001447362-25-000012 | EDGAR | 1K words |
115 total filings indexed. 86 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| Call Date | Quarter | Title |
|---|---|---|
| — | CSTL Earnings Call Transcript |
Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.
| CIK | 0001447362 |
| Ticker | CSTL |
| Exchange | Nasdaq |
| SIC | 8071: Services-Medical Laboratories |
| Incorporated | DE |
| Website | https://www.castlebiosciences.com |
| Listed | 2019-07-25 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CSTL (~200 tokens, structured JSON with cryptographic provenance)